| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.076 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |